Antibiotic-loving bacteria don't just resist drugs, they get a kick out of them


By www.sci-news.com

A team of scientists at the University of Exeter, UK, exposed Escherichia coli (E. coli) bacteria to eight rounds of antibiotic treatment over four days and found the bacteria had increased antibiotic resistance with each treatment.

This had been expected, but the authors were surprised to find mutated E. coli reproduced faster than before encountering the drugs and formed populations that were three times larger because of the mutations.

This was only seen in bacteria exposed to antibiotics — and when the team took the drug away, the evolutionary changes were not undone and the new-found abilities remained.

“Our research suggests there could be added benefits for E.coli bacteria when they evolve resistance to clinical levels of antibiotics,” said University of Exeter Professor Robert Beardmore, lead author on the study.

“It’s often said that Darwinian evolution is slow, but nothing could be further from the truth, particularly when bacteria are exposed to antibiotics.”

“Bacteria have a remarkable ability to rearrange their DNA and this can stop drugs working, sometimes in a matter of days. While rapid DNA change can be dangerous to a human cell, to a bacterium like E. coli it can have multiple benefits, provided they hit on the right changes.”

Prof. Beardmore and co-authors tested the effects of the antibiotic doxycycline on E. coli as part of a study of DNA changes brought about by antibiotics.

The bacteria that subsequently evolved was safely frozen at minus 80 degrees Celsius and the scientists used genetic sequencing to find out which DNA changes were responsible for its unusual evolution.

Some changes are well known and have been seen in clinical patients, like E. coli producing more antibiotic pumps that bacteria exploit to push antibiotics out of the cell. Another change saw the loss of DNA that is known to describe a dormant virus.

“Our best guess is that losing viral DNA stops the E.coli destroying itself, so we see more bacterial cells growing once the increase in pump DNA allows them to resist the antibiotic in the first place,” said study first author Dr. Carlos Reding-Roman.

“This creates an evolutionary force for change on two regions of the E. coli genome.”

“Normally, self-destruction can help bacteria colonize surfaces through the production of biofilms. You see biofilms in a dirty sink when you look down the plughole. But our study used liquid conditions, a bit like the bloodstream, so the E. coli could give up on its biofilm lifestyle in favor of increasing cell production.”

“It is said by some that drug resistance evolution doesn’t take place at high dosages but our paper shows that it can and that bacteria can change in ways that would not be beneficial for the treatment of certain types of infection. This shows it’s important to use the right antibiotic on patients as soon as possible so we don’t see adaptations like these in the clinic,” said co-author Dr. Mark Hewlett.

_____

C. Reding-Roman et al. 2017. The unconstrained evolution of fast and efficient antibiotic-resistant bacterial genomes. Nat. Ecol. Evol. 1: 0050; doi: 10.1038/s41559-016-0050

Source: http://www.sci-news.com/medicine/antibiotics-stimulate-bacterial-reproduction-04581.html


the viagra triangle chicago cialis 5mg online chi soffre di pressione alta puo prendere il cialis cialis usa order viagra and cialis online cialis 20mg online nizoral and cialis viagra online cialis with prescription online generic cialis embarrassed to go to doctor for viagra viagra canada viagra + other pills viagra canada blue pill that looks like viagra viagra 100mg online cialis hat nicht geholfen cialis online bula do remédio cialis cialis 20mg online

Monday, May 18, 2026

Colchicine - Gout - Patient guide - Quick tips

Colchicine affordability and refill continuity can influence flare control when patients manage recurrent gout over long periods. Cost is not only burden; flare-related pain, missed work, sleep loss, and urgent visits can also escalate total impact. Better outcomes usually come from combining affordability planning with strict dose safety and symptom tracking. Before follow-up appointments, patients can review colchicine treatment options and list refill barriers. Practical cost planning should include insurance tier checks, pharmacy comparisons, refill quantity limits, and expected monthly out-of-pocket changes. Comparing options before supply runs low can prevent treatment interruptions. If costs rise, clinicians and pharmacists can discuss safer alternatives or schedule adjustments. Monitoring remains essential during cost-driven changes. Patients should track flare onset timing, pain severity, swelling progression, hydration level, trigger foods, alcohol use, and exact dose timing. Early reassessment after worsening symptoms can reduce prolonged instability. Safety counseling should emphasize dose-limit adherence and urgent-warning awareness. Patients should seek immediate review for persistent gastrointestinal symptoms, progressive weakness, dehydration signs, chest symptoms, or concerning neurologic changes. Supportive routines still matter regardless of medication price. Hydration goals, trigger moderation, sleep stability, weight-management efforts, and regular follow-up can lower recurrence risk. Medication reconciliation at each visit helps identify interaction risks that may elevate colchicine toxicity potential. Patients should bring complete lists of prescriptions, over-the-counter products, and supplements. For broader gout-management planning and prevention tools, patients can use gout support resources and keep written logs for clinic review. Reliable colchicine outcomes usually come from affordability planning, strict safety adherence, and timely reassessment when warning signs appear. Patients who verify refill costs early and maintain weekly flare logs often avoid interruptions that can trigger severe recurrence. Written dose-limit reminders and toxicity-warning plans improve medication safety during high-risk periods. Routine follow-up and lab review support durable gout stability. Consistent adherence matters.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)